CRIS Current Research Information System

GALLINELLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.413
NA - Nord America 8.229
EU - Europa 6.019
AF - Africa 466
SA - Sud America 446
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 23.587
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.108
VN - Vietnam 2.365
CN - Cina 2.318
SG - Singapore 1.996
IT - Italia 1.461
GB - Regno Unito 1.359
DE - Germania 671
HK - Hong Kong 545
SE - Svezia 495
FR - Francia 413
IN - India 389
UA - Ucraina 369
RU - Federazione Russa 322
BR - Brasile 304
IE - Irlanda 205
KR - Corea 182
JP - Giappone 154
CH - Svizzera 139
ZA - Sudafrica 128
EE - Estonia 109
NL - Olanda 106
FI - Finlandia 92
CI - Costa d'Avorio 87
TG - Togo 85
AR - Argentina 83
BG - Bulgaria 73
CA - Canada 68
BD - Bangladesh 61
SC - Seychelles 59
IQ - Iraq 50
TH - Thailandia 44
JO - Giordania 41
NG - Nigeria 41
IR - Iran 39
AT - Austria 38
ID - Indonesia 37
BE - Belgio 34
PH - Filippine 32
PL - Polonia 32
MX - Messico 31
PK - Pakistan 31
TW - Taiwan 28
ES - Italia 27
TR - Turchia 20
SA - Arabia Saudita 18
CO - Colombia 14
KE - Kenya 13
EG - Egitto 12
RO - Romania 11
UZ - Uzbekistan 11
EC - Ecuador 10
GR - Grecia 10
LB - Libano 10
CZ - Repubblica Ceca 9
LT - Lituania 9
AU - Australia 8
CL - Cile 8
CM - Camerun 8
DO - Repubblica Dominicana 8
PE - Perù 8
VE - Venezuela 8
MY - Malesia 7
HR - Croazia 6
MA - Marocco 6
OM - Oman 6
PY - Paraguay 6
RS - Serbia 6
TN - Tunisia 6
AZ - Azerbaigian 5
CY - Cipro 4
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
YE - Yemen 4
LV - Lettonia 3
TZ - Tanzania 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
KH - Cambogia 2
KZ - Kazakistan 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
TD - Ciad 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BJ - Benin 1
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
Totale 23.567
Salva come PNG Salva come JPEG
Città #
Singapore 1.298
Southend 1.166
Ashburn 916
Fairfield 673
Chandler 589
Dong Ket 514
Hong Kong 511
San Jose 499
Ho Chi Minh City 470
Hefei 426
Hanoi 397
Seattle 341
Wilmington 325
Woodbridge 318
Bologna 295
Princeton 277
Houston 256
Dallas 253
Jacksonville 248
Ann Arbor 231
Cambridge 226
Beijing 225
Santa Clara 218
Dublin 204
Boardman 190
Seoul 161
Lauterbourg 146
Tokyo 134
Padova 129
Westminster 127
Los Angeles 124
Bern 121
Nanjing 120
New York 119
Council Bluffs 116
Milan 110
Berlin 99
Abidjan 87
Lomé 85
Buffalo 79
Helsinki 78
Sofia 72
Medford 71
Jinan 69
Haiphong 64
Saint Petersburg 63
Shenyang 63
Shanghai 55
Changsha 52
Da Nang 49
Zhengzhou 48
Tianjin 47
Hebei 46
Mülheim 46
Bengaluru 45
Redondo Beach 43
Amman 41
Parma 41
Nanchang 39
Abeokuta 37
Florence 37
Rome 37
San Diego 37
Buenos Aires 34
Guangzhou 33
São Paulo 33
Frankfurt am Main 32
Bremen 31
Brussels 31
Phoenix 31
Redwood City 31
Fremont 28
Hangzhou 28
Mahé 27
Biên Hòa 26
Dearborn 25
Jiaxing 25
London 25
Toronto 24
San Francisco 23
Verona 23
Yubileyny 23
Des Moines 22
Pune 22
Hải Dương 21
Ningbo 21
Vienna 21
Bangkok 20
Olalla 20
Taizhou 20
Warsaw 20
Modena 19
Atlanta 18
Johannesburg 18
Paris 18
Shenzhen 18
Turin 18
Thái Nguyên 17
Munich 16
Shijiazhuang 16
Totale 14.881
Salva come PNG Salva come JPEG
Nome #
Comparison of HPV sign Genotyping Test with INNO-LiPA HPV Genotyping Extra assay on histologic and cytologic cervical specimens 331
Antiviral activity of brincidofovir on parvovirus B19 290
Restriction Factors expression decreases in HIV-1 patients after cART 276
Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy 258
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 251
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 243
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 234
No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions 226
Antiviral effect of cidofovir on parvovirus B19 replication 222
Next Generation Sequencing for the Analysis of Parvovirus B19 Genomic Diversity 216
Advances in the development of antiviral strategies against parvovirus B19 214
Characterization of the human DNA gut virome across populations with different subsistence strategies and geographical origin 212
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 211
The clinical use of parvovirus B19 assays: recent advances 210
A Parvovirus B19 synthetic genome: sequence features and functional competence 207
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 202
Synthesis of 3-(Imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one derivatives and study of their antiviral activity against parvovirus B19 202
A Functional Minigenome of Parvovirus B19 202
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 199
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 198
A portable Microfluidic Device Based on Chemiluminescence Contact Imaging for detecting Parvovirus B19 in serum samples 198
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 196
Antiviral effect of Hydroxyurea on B19V replication 193
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 192
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 192
A loop mediated isothermal amplification (LAMP) assay to detect viral DNA in clinical specimens: BK polyomavirus and parvovirus B19 191
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 190
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 187
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 187
A proteomic approach to the analysis of B19 capsid proteins 187
On-chip LAMP-BART reaction for viral DNA real-time bioluminescence detection 187
Detection of viral DNA by isothermal NASBA amplification and chemiluminescence gene probe hybridization assay in a microfluidic cartridge 186
Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012–2024: COVID‐19 Pre‐Pandemic, Pandemic and Post‐Pandemic Trends 184
Parvovirus B19 Achievements and Challenges 183
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 182
Analisi della competenza funzionale di cloni genomici di parvovirus B19 181
Parvoviridae 181
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 180
Mesenchymal stem cells are susceptible but non-permissive to B19V replication 180
Targeting Parvovirus B19: antiviral strategies reviewed 177
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 177
Importin α/β-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication 176
Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas 176
Non-Permissive Parvovirus B19 Infection: A Reservoir and Questionable Safety Concern in Mesenchymal Stem Cells 174
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 174
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 174
Recurrent erythema in patients with long-term parvovirus B19 infection 173
A flow-FISH assay for the quantitative analysis of parvovirus B19 infected cells 172
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 171
Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells 170
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 166
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 166
Parvovirus B19-derived fetal complications following gestational infection. 166
Back from the past: Parvovirus B19 Genotype III DNA in the mummies of the Hermit Poor Clares of Fara in Sabina, Italy 165
Parvovirus B19 DNA detection in serum samples employing a microfluidic device based on chemiluminescence contact imaging. 165
Avermectins Inhibit Replication of Parvovirus B19 by Disrupting the Interaction Between Importin α and Non-Structural Protein 1 164
Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells 164
Simian parvovirus infection: a potential zoonosis 163
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 163
Analysis at single cell level of parvovirus B19 expression process by chemiluminescent microscope imaging assays 162
Analysis of the functional competence of genomic clones of Parvovirus B19 162
Parvovirus B19 in Rheumatic Diseases 159
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 158
Development of chemiluminescent assays for the quantitative detection and imaging of 5-bromo-2'deoxyuridine-labeled DNA in parvovirus B19-infected cells 158
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 157
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 157
Preliminary bioinformatic evaluation via Snakemake pipeline applied to 17th-18th century mummified specimens 156
How does parvovirus B19 DNA achieve lifelong persistence in human cells? 156
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 155
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 154
Placental endothelial cells can be productively infected by Parvovirus B19 154
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 154
Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay 153
Portable chemiluminescence multiplex biosensor for quantitative detection of three B19 DNA genotypes 153
Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells 153
Microfluidic cartridge with integrated array of amorphous silicon photosensors for chemiluminescence detection of viral DNA 152
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 151
A loop-mediated isothermal amplification (LAMP) assay to detect parvovirus B19 DNA in clinical samples 151
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 151
Evidence of human bocavirus viremia in healthy blood donors. 151
Antiviral Activity of Cannabidiolic Acid and Its Methyl Ester against SARS-CoV-2 149
Analysis on Parvovirus B19 life cycle at single cell level by chemiluminescent imaging assays 148
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 148
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 144
Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays 143
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones 142
Parvovirus B19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease 142
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 141
Implicazioni nella progressione della patologia cervicale 140
Reassembling in vitro the niche of Parvovirus B19 infection: a stem cell co-culture model 138
Tecniche di amplificazione real-time nella determinazione della carica virale: parvovirus B19 e papillomavirus umani 138
Sviluppo di un dispositivo analitico miniaturizzato “Point-of-Care Testing” per la diagnosi di infezione da parvovirus B19 138
Gastrointestinal lesions in parvovirus B19 infection 136
Cellule progenitrici eritroidi ottenute da sangue periferico come sistema per lo studio della replicazione ed espressione di B19V 135
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 134
Antiviral effect of Cidofovir on B19V replication 133
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 132
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 132
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 132
Bone marrow necrosis and fat embolism syndrome in sickle cell disease: Increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. 130
Totale 17.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.544
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021845 0 0 0 0 0 0 0 0 0 0 0 845
2021/20222.442 232 124 119 193 205 126 55 169 89 197 492 441
2022/20232.561 282 345 128 316 157 168 77 122 423 50 232 261
2023/20241.222 46 127 75 147 101 252 84 94 56 70 83 87
2024/20253.210 152 490 320 233 420 173 282 100 62 159 190 629
2025/20268.139 755 1.070 901 633 870 410 673 249 1.462 573 357 186
Totale 24.049